• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

鉴定细丝蛋白-A和-B作为前列腺癌的潜在生物标志物。

Identification of Filamin-A and -B as potential biomarkers for prostate cancer.

作者信息

Narain Niven R, Diers Anne R, Lee Arleide, Lao Socheata, Chan Joyce Y, Schofield Sally, Andreazi Joe, Ouro-Djobo Rakibou, Jimenez Joaquin J, Friss Tracey, Tanna Nikunj, Dalvi Aditee, Wang Sihe, Bunch Dustin, Sun Yezhou, Wu Wenfang, Thapa Khampaseuth, Gesta Stephane, Rodrigues Leonardo O, Akmaev Viatcheslav R, Vishnudas Vivek K, Sarangarajan Rangaprasad

机构信息

Berg, LLC, Framingham, MA, USA; Berg, LLC, Framingham, MA, USA.

Department of Dermatology, University of Miami Miller School of Medicine, Miami, FL, USA 33136; Department of Dermatology, University of Miami Miller School of Medicine, Miami, FL, USA 33136.

出版信息

Future Sci OA. 2016 Dec 22;3(1):FSO161. doi: 10.4155/fsoa-2016-0065. eCollection 2017 Mar.

DOI:10.4155/fsoa-2016-0065
PMID:28344825
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5351499/
Abstract

AIM

A novel strategy for prostate cancer (PrCa) biomarker discovery is described.

MATERIALS & METHODS: perturbation biology, proteomics and Bayesian causal analysis identified biomarkers that were validated in models and clinical specimens.

RESULTS

Filamin-B (FLNB) and Keratin-19 were identified as biomarkers. Filamin-A (FLNA) was found to be causally linked to FLNB. Characterization of the biomarkers in a panel of cells revealed differential mRNA expression and regulation. Moreover, FLNA and FLNB were detected in the conditioned media of cells. Last, in patients without PrCa, FLNA and FLNB blood levels were positively correlated, while in patients with adenocarcinoma the relationship is dysregulated.

CONCLUSION

These data support the strategy and the potential use of the biomarkers for PrCa.

摘要

目的

描述一种用于前列腺癌（PrCa）生物标志物发现的新策略。

材料与方法

通过扰动生物学、蛋白质组学和贝叶斯因果分析确定了在模型和临床标本中得到验证的生物标志物。

结果

细丝蛋白-B（FLNB）和角蛋白-19被鉴定为生物标志物。发现细丝蛋白-A（FLNA）与FLNB存在因果联系。在一组细胞中对这些生物标志物的表征揭示了不同的mRNA表达和调控。此外，在细胞的条件培养基中检测到了FLNA和FLNB。最后，在无PrCa的患者中，FLNA和FLNB的血液水平呈正相关，而在腺癌患者中这种关系失调。

结论

这些数据支持该策略以及这些生物标志物在PrCa中的潜在应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7066/5351499/2fd98081a0da/fsoa-03-161-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7066/5351499/ae92e8bb026d/fsoa-03-161-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7066/5351499/ff57c9034662/fsoa-03-161-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7066/5351499/c44a43049261/fsoa-03-161-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7066/5351499/2fd98081a0da/fsoa-03-161-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7066/5351499/ae92e8bb026d/fsoa-03-161-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7066/5351499/ff57c9034662/fsoa-03-161-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7066/5351499/c44a43049261/fsoa-03-161-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7066/5351499/2fd98081a0da/fsoa-03-161-g4.jpg

相似文献

1
Identification of Filamin-A and -B as potential biomarkers for prostate cancer.鉴定细丝蛋白-A和-B作为前列腺癌的潜在生物标志物。
Future Sci OA. 2016 Dec 22;3(1):FSO161. doi: 10.4155/fsoa-2016-0065. eCollection 2017 Mar.
2
Clinical Validation of a Serum Protein Panel (FLNA, FLNB and KRT19) for Diagnosis of Prostate Cancer.用于前列腺癌诊断的血清蛋白组（FLNA、FLNB和KRT19）的临床验证
J Mol Biomark Diagn. 2017;8(2). doi: 10.4172/2155-9929.1000323. Epub 2017 Feb 8.
3
Filamin A and Filamin B are co-expressed within neurons during periods of neuronal migration and can physically interact.细丝蛋白A和细丝蛋白B在神经元迁移期间在神经元内共同表达，并且可以发生物理相互作用。
Hum Mol Genet. 2002 Nov 1;11(23):2845-54. doi: 10.1093/hmg/11.23.2845.
4
Opposing FlnA and FlnB interactions regulate RhoA activation in guiding dynamic actin stress fiber formation and cell spreading.FlnA和FlnB的相互作用相反，在引导动态肌动蛋白应力纤维形成和细胞铺展过程中调节RhoA激活。
Hum Mol Genet. 2017 Apr 1;26(7):1294-1304. doi: 10.1093/hmg/ddx047.
5
Targeting filamin B induces tumor growth and metastasis via enhanced activity of matrix metalloproteinase-9 and secretion of VEGF-A.靶向细丝蛋白 B 通过增强基质金属蛋白酶-9 的活性和 VEGF-A 的分泌促进肿瘤生长和转移。
Oncogenesis. 2014 Sep 22;3(9):e119. doi: 10.1038/oncsis.2014.33.
6
Disruption of the Flnb gene in mice phenocopies the human disease spondylocarpotarsal synostosis syndrome.小鼠中Flnb基因的破坏模拟了人类疾病脊椎腕跗骨融合综合征。
Hum Mol Genet. 2008 Mar 1;17(5):631-41. doi: 10.1093/hmg/ddm188. Epub 2007 Jul 17.
7
Disease-associated substitutions in the filamin B actin binding domain confer enhanced actin binding affinity in the absence of major structural disturbance: Insights from the crystal structures of filamin B actin binding domains.细丝蛋白B肌动蛋白结合结构域中与疾病相关的替代在无主要结构紊乱的情况下赋予增强的肌动蛋白结合亲和力：来自细丝蛋白B肌动蛋白结合结构域晶体结构的见解
J Mol Biol. 2009 Jul 31;390(5):1030-47. doi: 10.1016/j.jmb.2009.06.009. Epub 2009 Jun 6.
8
New cancer suppressor gene for colorectal adenocarcinoma: filamin A.结直肠癌的新型抑癌基因：细丝蛋白A。
World J Gastroenterol. 2015 Feb 21;21(7):2199-205. doi: 10.3748/wjg.v21.i7.2199.
9
Filamin B mutations cause chondrocyte defects in skeletal development.细丝蛋白B突变导致骨骼发育中的软骨细胞缺陷。
Hum Mol Genet. 2007 Jul 15;16(14):1661-75. doi: 10.1093/hmg/ddm114. Epub 2007 May 17.
10
Disease-associated mutations in the actin-binding domain of filamin B cause cytoplasmic focal accumulations correlating with disease severity.肌动蛋白结合域中的细丝蛋白 B 相关疾病突变导致细胞质局灶性聚集，与疾病严重程度相关。
Hum Mutat. 2012 Apr;33(4):665-73. doi: 10.1002/humu.22012. Epub 2012 Jan 23.

引用本文的文献

1
The Potential of Extracellular Matrix- and Integrin Adhesion Complex-Related Molecules for Prostate Cancer Biomarker Discovery.细胞外基质和整合素黏附复合体相关分子在前列腺癌生物标志物发现中的潜力
Biomedicines. 2023 Dec 28;12(1):79. doi: 10.3390/biomedicines12010079.
2
The expression profile of Gasdermin C-related genes predicts the prognosis and immunotherapy response of pancreatic adenocarcinoma.Gasdermin C相关基因的表达谱可预测胰腺腺癌的预后及免疫治疗反应。
Am J Cancer Res. 2023 Apr 15;13(4):1240-1258. eCollection 2023.
3
Exploiting Interdata Relationships in Prostate Cancer Proteomes: Clinical Significance of HO-1 Interactors.

本文引用的文献

1
Homeostasis of redox status derived from glucose metabolic pathway could be the key to understanding the Warburg effect.源自葡萄糖代谢途径的氧化还原状态的稳态可能是理解瓦伯格效应的关键。
Am J Cancer Res. 2015 Feb 15;5(3):928-44. eCollection 2015.
2
Prostate-specific antigen-based prostate cancer screening: Past and future.基于前列腺特异性抗原的前列腺癌筛查：过去与未来
Int J Urol. 2015 Jun;22(6):524-32. doi: 10.1111/iju.12750. Epub 2015 Apr 6.
3
Proteomic profile of the skin mucus of farmed gilthead seabream (Sparus aurata).养殖金头鲷（Sparus aurata）皮肤黏液的蛋白质组学特征
利用前列腺癌蛋白质组中的数据间关系：血红素加氧酶-1相互作用分子的临床意义
Antioxidants (Basel). 2022 Jan 31;11(2):290. doi: 10.3390/antiox11020290.
4
Exploration of Extracellular Vesicle miRNAs, Targeted mRNAs and Pathways in Prostate Cancer: Relation to Disease Status and Progression.前列腺癌中细胞外囊泡miRNA、靶向mRNA及信号通路的探索：与疾病状态和进展的关系
Cancers (Basel). 2022 Jan 21;14(3):532. doi: 10.3390/cancers14030532.
5
Identifying Critical States of Complex Diseases by Single-Sample Jensen-Shannon Divergence.通过单样本 Jensen-Shannon 散度识别复杂疾病的关键状态。
Front Oncol. 2021 Jun 4;11:684781. doi: 10.3389/fonc.2021.684781. eCollection 2021.
6
Association between Venom Immunotherapy and Changes in Serum Protein-Peptide Patterns.毒液免疫疗法与血清蛋白质-肽谱变化之间的关联。
Vaccines (Basel). 2021 Mar 12;9(3):249. doi: 10.3390/vaccines9030249.
7
Biomarkers That Differentiate Benign Prostatic Hyperplasia from Prostate Cancer: A Literature Review.区分良性前列腺增生与前列腺癌的生物标志物：文献综述
Cancer Manag Res. 2020 Jul 1;12:5225-5241. doi: 10.2147/CMAR.S250829. eCollection 2020.
8
High-throughput proteomic analysis of FFPE tissue samples facilitates tumor stratification.高通量蛋白质组学分析 FFPE 组织样本有助于肿瘤分层。
Mol Oncol. 2019 Nov;13(11):2305-2328. doi: 10.1002/1878-0261.12570. Epub 2019 Sep 18.
9
Biological roles of filamin a in prostate cancer cells.层粘连蛋白 A 在前列腺癌细胞中的生物学作用。
Int Braz J Urol. 2019 Sep-Oct;45(5):916-924. doi: 10.1590/S1677-5538.IBJU.2018.0535.
10
Exosome proteomic analyses identify inflammatory phenotype and novel biomarkers in African American prostate cancer patients.外泌体蛋白质组分析鉴定非裔美国前列腺癌患者的炎症表型和新型生物标志物。
Cancer Med. 2019 Mar;8(3):1110-1123. doi: 10.1002/cam4.1885. Epub 2019 Jan 8.
J Proteomics. 2015 Apr 29;120:21-34. doi: 10.1016/j.jprot.2015.02.019. Epub 2015 Mar 6.
4
Challenges and opportunities for cell line secretomes in cancer proteomics.癌症蛋白质组学中细胞系分泌蛋白质组面临的挑战与机遇
Proteomics Clin Appl. 2015 Apr;9(3-4):348-57. doi: 10.1002/prca.201400131. Epub 2015 Feb 10.
5
Combined genome and transcriptome analysis of single disseminated cancer cells from bone marrow of prostate cancer patients reveals unexpected transcriptomes.对前列腺癌患者骨髓中单个播散癌细胞的基因组和转录组联合分析揭示了意想不到的转录组。
Cancer Res. 2014 Dec 15;74(24):7383-94. doi: 10.1158/0008-5472.CAN-14-0934. Epub 2014 Oct 15.
6
Molecular pathways and targets in prostate cancer.前列腺癌中的分子途径与靶点
Oncotarget. 2014 Sep 15;5(17):7217-59. doi: 10.18632/oncotarget.2406.
7
Targeting filamin B induces tumor growth and metastasis via enhanced activity of matrix metalloproteinase-9 and secretion of VEGF-A.靶向细丝蛋白 B 通过增强基质金属蛋白酶-9 的活性和 VEGF-A 的分泌促进肿瘤生长和转移。
Oncogenesis. 2014 Sep 22;3(9):e119. doi: 10.1038/oncsis.2014.33.
8
Redox regulation of cancer metastasis: molecular signaling and therapeutic opportunities.癌症转移的氧化还原调节：分子信号传导与治疗机会
Drug Dev Res. 2014 Aug;75(5):331-41. doi: 10.1002/ddr.21216.
9
Biomarkers in prostate cancer: what's new?前列腺癌中的生物标志物：有哪些新进展？
Curr Opin Oncol. 2014 May;26(3):259-64. doi: 10.1097/CCO.0000000000000065.
10
Validation of proposed prostate cancer biomarkers with gene expression data: a long road to travel.利用基因表达数据验证前列腺癌生物标志物：漫长的征程。
Cancer Metastasis Rev. 2014 Sep;33(2-3):657-71. doi: 10.1007/s10555-013-9470-4.